Galderma Laboratories, L.P. et al v. Dr. Reddy's Laboratories, Ltd. et al
Galderma Laboratories, L.P. and TCD Royalty Sub LP |
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. |
1:2023cv00711 |
June 30, 2023 |
US District Court for the District of Delaware |
Stephanos Bibas |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on August 24, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 12 SO ORDERED, re #11 STIPULATION TO EXTEND TIME for Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. to move, answer, or otherwise respond to the Complaint to September 7, 2023. Signed by Judge Stephanos Bibas on 8/24/2023. (mpb) |
Filing 11 STIPULATION TO EXTEND TIME for Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. to move, answer, or otherwise respond to the Complaint to September 7, 2023 - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
Filing 10 SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendants Dr. Reddy's Laboratories, LTD. and Dr. Reddy's Laboratories, Inc. to move, answer, or otherwise respond to the Complaint to August 23, 2023. Ordered by Judge Stephanos Bibas on 7/19/2023. (twk) |
Filing 9 STIPULATION TO EXTEND TIME for Defendants Dr. Reddy's Laboratories, LTD. and Dr. Reddy's Laboratories, Inc. to move, answer, or otherwise respond to the Complaint to August 23, 2023 - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
Case Assigned to Judge Stephanos Bibas of the United States Court of Appeals for the Third Circuit (due to related cases). Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) |
Filing 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Dr. Reddys Laboratories, Ltd. on June 30, 2023, filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
Filing 7 AFFIDAVIT of Service for Summons, Complaint and related papers served on Dr. Reddys Laboratories, Inc. on June 30, 2023, filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
Filing 6 Summons Issued as to Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. on 6/30/2023. (Attachments: #1 Summons Issued to Dr. Reddys Laboratories, Ltd.)(jfm) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Drug Royalty III LP 2, Corporate Parent DRI Healthcare Trust for TCD Royalty Sub LP; Corporate Parent Galderma Services Inc. for Galderma Laboratories, L.P. filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (jfm) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (jfm) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 18, 2023. Date of Expiration of Patent: December 24, 2025 (U.S. Patent No. 8,206,740) & December 19, 2027 (U.S. Patent No. 7,749,532).Thirty Month Stay Deadline: 11/18/2025. (jfm) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4169684.) - filed by TCD Royalty Sub LP, Galderma Laboratories, L.P. (Attachments: #1 Exhibits, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.